Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-10-002099
Filing Date
2010-01-06
Accepted
2010-01-06 18:26:42
Documents
1
Period of Report
2009-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 2762
  Complete submission text file 0001209191-10-002099.txt   4508
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address
Edwards Robert (Reporting) CIK: 0001408671 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-33637 | Film No.: 10512971